Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

conversion surgery

  • You have access
    Impact of Nivolumab Plus Chemotherapy on Conversion Therapy in Clinical Stage IVB HER2-negative Gastric Cancer
    YUDAI HOJO, TOSHIHIKO TOMITA, MASATAKA IGETA, MOTOKI MURAKAMI, SHUGO KOHNO, EIICHIRO NAKAO, YOSHITAKA KITAYAMA, TATSURO NAKAMURA, YASUNORI KURAHASHI, YOSHINORI ISHIDA, SEIICHI HIROTA, SHINICHIRO SHINZAKI and HISASHI SHINOHARA
    Anticancer Research May 2025, 45 (5) 2091-2102; DOI: https://doi.org/10.21873/anticanres.17583
  • You have access
    Clinical Significance of Body Weight Loss During Chemotherapy for Advanced Gastric Cancer Undergoing Conversion Surgery
    TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, MASATAKA SHIMONOSONO, YUKI HIRASE, YUSUKE TSURUDA, KEN SASAKI, KENJI BABA and TAKAO OHTSUKA
    Anticancer Research September 2024, 44 (9) 4031-4037; DOI: https://doi.org/10.21873/anticanres.17232
  • You have access
    A Multidisciplinary Therapeutic Approach Proposal for Huge Hepatocellular Carcinomas Exceeding 10 cm in Diameter
    YUICHI GOTO, TAKASHI NIIZEKI, HISAMUNE SAKAI, MASANORI AKASHI, SHOGO FUKUTOMI, KAZUAKI HASHIMOTO, HIDEKI IWAMOTO, SHIGEO SHIMOSE, TOMOTAKE SHIRONO, TAKEFUMI YOSHIDA, TARO ISOBE, NAOKI MORI, TAKUMI KAWAGUCHI, NOBUYA ISHIBASHI, FUMIHIKO FUJITA and TORU HISAKA
    Anticancer Research August 2024, 44 (8) 3629-3636; DOI: https://doi.org/10.21873/anticanres.17186
  • You have access
    Re-consideration of Lymph Node Metastasis in Pancreatic Cancer Patients Following Radical Resection: A Retrospective Study
    RYO SAITO, HIROMICHI KAWAIDA, WATARU IZUMO, YUUKI NAKATA, HIDETAKE AMEMIYA, TAKAOMI OZAWA, YUDAI HIGUCHI, TAKASHI NAKAYAMA, SUGURU MARUYAMA, KOICHI TAKIGUCHI, KATSUTOSHI SHODA, NAOKI ASHIZAWA, YUKO NAKAYAMA, KENSUKE SHIRAISHI, SHINJI FURUYA, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI and DAISUKE ICHIKAWA
    Anticancer Research May 2024, 44 (5) 2141-2149; DOI: https://doi.org/10.21873/anticanres.17020
  • You have access
    Comparative Effectiveness of Cetuximab Versus Panitumumab in Patients With Metastatic Colorectal Cancer: A Nationwide Database Study
    CHIH-CHIEN WU, CHIEN-CHOU SU, YU-HSUN CHEN, CHAO-WEN HSU, MENG-CHE HSIEH, YU-CHING CHANG, YUNG-CHANG WANG and YI-CHIA SU
    Anticancer Research November 2023, 43 (11) 5127-5138; DOI: https://doi.org/10.21873/anticanres.16713
  • Open Access
    CA19-9 With Two-stage Resection Is Useful for Conversion Surgery in PDAC With Synchronous Oligometastases
    KOETSU INOUE, MASAMICHI MIZUMA, FUYUHIKO MOTOI, TAKASHI KOKUMAI, HIDEAKI SATO, AKIKO KUSAKA, SHUICHI AOKI, MASAHIRO ISEKI, DAISUKE DOUCHI, TAKAYUKI MIURA, SHIMPEI MAEDA, MASAHARU ISHIDA, HIDEO OHTSUKA, KEI NAKAGAWA, TAKASHI KAMEI and MICHIAKI UNNO
    Anticancer Research November 2023, 43 (11) 5223-5234; DOI: https://doi.org/10.21873/anticanres.16724
  • Open Access
    Preoperative Therapy for Unresectable Locally Advanced Pancreatic Cancer for ≥6 Months Improves Prognosis After Pancreatectomy
    MICHINORI MATSUMOTO, YOSHIHIRO SHIRAI, TADASHI UWAGAWA, MASASHI TSUNEMATSU, TARO SAKAMOTO, SHUICHI FUJIOKA, KEITA TAKAHASHI, SHINJI ONDA, KENEI FURUKAWA, KOICHIRO HARUKI, RYOGA HAMURA, TAKESHI GOCHO and TORU IKEGAMI
    Anticancer Research September 2023, 43 (9) 4097-4104; DOI: https://doi.org/10.21873/anticanres.16599
  • You have access
    Clinical Significance of Recurrence Risk Score for Conversion Surgery in Patients With Advanced Gastric Cancer
    TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, MASATAKA SHIMONOSONO, YUSUKE TSURUDA, KEN SASAKI, KENJI BABA, MASUMI WADA, NAOKI KUROSHIMA, HIROSHI KURAHARA and TAKAO OHTSUKA
    Anticancer Research July 2023, 43 (7) 3305-3310; DOI: https://doi.org/10.21873/anticanres.16506
  • You have access
    A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular Carcinoma
    HIRONORI SHIOZAKI, KENEI FURUKAWA, KOICHIRO HARUKI, MICHINORI MATSUMOTO, TADASHI UWAGAWA, SHINJI ONDA, YUTO YAMAHATA, SHUNTA ISHIZAKI, KYOHEI ABE, SHUICHI FUJIOKA, YUICHI NAKASEKO, TOMOYOSHI OKAMOTO and TORU IKEGAMI
    Anticancer Research April 2023, 43 (4) 1761-1766; DOI: https://doi.org/10.21873/anticanres.16329
  • You have access
    Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel
    YASUSHI IDE, TAIGA OTSUKA, MOTOTSUGU SHIMOKAWA, FUTA KOGA, YUJIRO UEDA, JUNICHI NAKAZAWA, AZUSA KOMORI, SATOSHI OTSU, SHIHO ARIMA, MASARU FUKAHORI, AKITAKA MAKIYAMA, YUDAI SHINOHARA, SHOHEI UENO, HIROKI TAGUCHI, TAKUYA HONDA, TARO SHIBUKI, KENTA NIO, NORIO URESHINO, TOSHIHIKO MIZUTA, KENJI MITSUGI and TSUYOSHI SHIRAKAWA
    Anticancer Research April 2023, 43 (4) 1817-1826; DOI: https://doi.org/10.21873/anticanres.16335

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire